 |
 |
 |
 |
| Home | Site Map | Contact Us | |||
 |
|||
 |
|||
 |
|||
 |
A
Guide to Drug Coverage under the Medicare Modernization Act (MMA): Key
Components for Pharmacists to Know
Please
read through the following information and click continue.
ACPE
Universal Program Number: 207-000-05-043-H03
Release Date: January 12, 2005
Expiration Date: January 12, 2008
Description
The Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (MMA) is considered the most significant change to the Medicare
program since it was created as Title XVIII of the Social Security Act
in 1965. The biggest revision to Medicare in the MMA is the addition of
drug coverage for beneficiaries. Adding the prescription drug benefit
as a new Part D of Medicare recognizes the central role that prescription
drugs play in our health care delivery system and the need to assure availability
of prescription drugs to Medicare beneficiaries. Since the drug benefit
is the biggest change in the MMA with potentially significant implications
for the profession of pharmacy, the prescription benefit will be the main
focus of this educational program. Pharmacists will need to evaluate the
implications of their participation in the program and the specifics of
prescription drug plans (PDPs) that will be available to patients in their
market area. This program contains a description of key components of
the new drug coverage under Medicare with particular relevance to pharmacists
such as structure of the benefit, access, formularies, pharmacist services,
and economic impact.
Learning
Objectives
Upon completion of this activity, the pharmacist should be better able
to:
- Explain the structure of the Medicare drug coverage program that will begin in 2006.
- Describe the role of prescription drug plans (PDPs) in the Medicare drug coverage program and discuss implications of PDPs for participating pharmacies and patients.
- Estimate the economic impact of participating in the Medicare drug coverage program on their pharmacy.
- Discuss the implications of aspects of the act that will affect pharmacists and patients, including formularies, mail service prescriptions, pharmacist services, Medicaid changes, existing coverages, and importation.
Target
Audience
Pharmacists
A score of 70 percent is required to successfully complete the CE quiz. You will have two opportunities to achieve a passing score.
The Statement of Credit should be printed upon receipt; a duplicate copy will be available in the participant's online transcript for further viewing. Individuals must complete this program by January 12, 2008.
NCPA
is approved by the Accreditation Council for Pharmacy Education as a provider
of continuing pharmacy education. This program will provide 1.5 contact
hour(s) (0.15 CEUs) of continuing pharmacy education credit under the
number 207-000-05-043-H03.
Faculty
Information
David
H. Kreling, Ph.D., is Professor and Hammel/Sanders Distinguished
Chair in Pharmacy Administration, School of Pharmacy, University of Wisconsin
- Madison.
Rachel A. Donatelle and Sean M. Schwartz,
are Pharm.D. students at the School of Pharmacy, University of Wisconsin
- Madison.
Jeanine L. Porter, Pharm.D.
is a graduate student in Social and Administrative Sciences in Pharmacy,
School of Pharmacy, University of Wisconsin - Madison.
Faculty
Disclosure Statements
NCPA has a conflict of interest policy that requires course
faculty to disclose any real or apparent commercial financial affiliations
related to the content of their presentations/materials.
Commercial
Supporter
This
program is supported by an educational grant from Boehringer Ingelheim. 
| PC Windows 98 SE or above Internet Explorer 5.5 or above Netscape 7.02 or above 800 x 600 Minimum Monitor Resolution *Adobe Acrobat Reader |
MAC |
| *REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON | |
